Show the full website


Lars Rasmussen sees no conflict in double chairmanship: "Although there's nothing to it, bad publicity could harm Ambu"

An anonymous email sent to several media, analysts and Ambu led the medtech company's chairman to resign from his post Thursday last week. In the email, an undisclosed group of equity holders question Rasmussen's impartiality. Personally, he refutes the notion that there's a conflict of interest.

Resigning Chairman of the Board at Ambu Lars Rasmussen. | Foto: Niels Hougaard/IND

After just one year in the role, Ambu's chairman of the board Lars Rasmussen has chosen not to run for another term at the medtech firm's general assembly in December. Rasmussen made this decision on Thursday afternoon last week, after receiving a particular email in his inbox.

A group of anonymous equity holders claimed that Rasmussen was subject to a conflict of interest by being the board chairman of both Coloplast and Ambu, after Coloplast, on the company's capital markets day, announced that it sees scopes as a potential future growth area for the firm.

Read this article for free

Register with your E-mail.
No credit card required.

Get full access for you and your coworkers.

Start a free company trial today

Receive newsletter from MedWatch today

NB: Subscribing to the newsletter is free.

More from MedWatch


See all jobs